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Serum iron level, ferritin and total iron binding 
capacity level among nonpregnant women 
with and without melasma
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Background: Melasma is a common acquired disorder characterized by symmetric, hyperpigmented patches with an irregular 
outline, occurring most commonly on the face. It is most prevalent among young to middle-aged women. Although iron overload 
affects skin pigmentation, effect of iron deficiency on skin is not clear. So, we evaluated serum iron level, ferritin and total iron 
binding capacity (TIBC) level among nonpregnant women with and without melasma. Materials and Methods: A cross-sectional 
case study was conducted in 2012 at university dermatologic department on 33 nonpregnant women with melasma (case) and 33 
nonpregnant women without melasma (control). Serum iron level, TIBC and ferritin in the two groups was measured and compared. 
Results: Serum iron level was lower in the case group (85 ± 11) in comparison with control group (102 ± 9), but the difference was 
not significant (P: 0.9). Mean TIBC and Ferritin were higher in the case group (TIBC: 329.4 ± 29, ferritin: 6 ± 18) than the control 
group (TIBC: 329.3 ± 29, ferritin: 33 ± 6) without significant difference. Conclusion: Although the serum iron level was lower in 
nonpregnant women with mealsma, it was not significant compared with those without melasma.
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hyperpigmentation all over the body, but melasma 
mostly involves places, which are exposed to the 
sun more frequently.[5] Melasma is the most common 
reason of skin hyperpigmentation, which its treatments 
are often ineffective as it comes back with continued 
exposure to the sun.[2,6,7] Iron, cobalt, Magnesium and 
selenium, Vitamin E and C are known to have effect 
on skin diseases progress,[8] but little data about serum 
iron level and melasma. Although iron overload affects 
skin pigmentation, effect of iron deficiency on skin is 
not clear. Hence, we evaluated serum iron level, ferritin 
and total iron binding capacity (TIBC) level among 
nonpregnant women with and without melasma.
MATERIALS AND METHODS
In a cross-sectional case-control study performed in 
2012 in university referral dermatologic clinic of Rasoul 
Akram and Razi Hospitals. We included patients who 
have melisma as a case group. Women with the history 
of cardiac or thyroid disease and usage of hormone 
therapy, phototoxic drugs or anti convulsant drugs or 
pregnancy were not included. Nonpregnant women 
without melisma were considered as the control group. 
INTRODUCTION
Melasma is a tan or dark skin discoloration mostly 
involves face and neck. Although it can affect any one, 
it is more common in women, especially pregnant 
women and those who are taking contraceptives or 
hormone replacement therapy. Melasma is thought 
to be the stimulation of melanocytes to produce more 
melanin pigments when there is sun exposure. Genetic 
predisposition is also an important factor in determining 
whether someone will develop melasma. Prevalence of 
melasma increases in patients with thyroid disease.[1-4] 
Melasma symptoms are dark, irregular well demarcated 
hyper pigmented macules to patches commonly found 
on the upper cheek, nose, lips and forehead.[3,4] When 
the skin is exposed to the sun the hyperpigmentation 
becomes darker which shows the effect of sun exposure 
in melasma pathophysiology.[4]
Hemochromatosis is an iron overload disease, originating 
from a metabolic disorder. It’s most common presentation 
is cirrhosis, hypopituitarism, cardiomyopathy, diabetes, 
arthritis or hyper pigmentation, which worsens by sun 

















How to cite this article: Behrangi E, Esmaeeli S, Baniasadi F, Hedayat K, Goodarzi A, Azizian Z.  Serum iron level, ferritin and total iron binding capacity 
level among nonpregnant women with and without melasma. J Res Med Sci 2015;20:281-3.
Behrangi, et al.: Serum iron level and melasma
Journal of Research in Medical Sciences| March 2015 | 282
After declaring sufficient information, a written consent was 
taken from all participants. Control and case groups were 
matched for demographic variables (age, marital status, 
body mass index and known related melasma disorder).
The checklist included three parts to collect data regarding 
demographic information, medical history, and medical 
examination. Both the interview and medical examination was 
done by a dermatologist. Melasma diagnosis was made based 
on clinical examination.[13] We also checked serum iron level, 
TIBC and Ferritin level of blood in both groups. We considered 
serum iron level 55-160 µg/dL, ferritin 11-306 ng/dL and TIBC 
228-428 µg/dL as normal amounts among our patients.[9]
Data were analyzed by Statistical Package for the Social 
Sciences (SPSS) for Windows (version 16.0; Chicago, IL, 
USA). Means were compared using independent t-test and 
proportions were compared using Chi-square test. Crude 
and adjusted odds ratios were calculated along with 95% 
confidence intervals.
The study was approved by Committee of Ethics in Iran 
University of medical sciences.
RESULTS
Thirty-three nonpregnant women with melasma (case) and 
33 nonpregnant women without melasm were evaluated 
during 1-year study. Results regarding the demographic 
variable have been shown in Table 1. Control and case 
groups were matched for demographic variables (age, 
marital status, body mass index and known related melasma 
disorder).
Mean (standard deviation) serum iron level, TIBC and 
ferritin is shown in Table 2.
In case group, 27% had a lower level of serum iron, and 
10% had upper serum iron level. In the control group, 15% 
were in the lower level and 10% upper level of serum iron 
(P > 0.05). About 23% of patients in the case group had low 
Ferritin level compared with 12% in the control group, but 
not statistically significant.
DISCUSSION
The mean serum iron level in the case group was a lower 
than the control group. We did not find a considerable 
relationship between serum iron level amount and 
melasma. However, Ping et al. found higher amounts of 
iron, magnesium, copper, and zinc among 46 nonpregnant 
women with melasma.[10] However Jie et al. showed higher 
iron and copper in women with melisma comparing with 
women without melasma.[11] We could not find any reason 
for this difference. Study with larger sample size may be 
suggested.
In our study, melasma was more observed in the age 
25-35 years old. Melasma is a common acquired disorder 
characterized by symmetric, hyperpigmented patches, which 
are most prevalent among young to middle-aged women.
We did not find any significant difference between case and 
control groups in TIBC and Ferritin between two groups. 
The prevalence of low iron serum was more in case group 
(27%) compared with the control group (15%). In a research 
conducted in 2012, 14.3% of patients with melasma also had 
low serum iron level.[12]
Melasma is an important cosmetic problem worldwide. 
There are different factors that have an effect on melasma. 
Considering the common dermatologic symptoms of iron 
overload disease (hemochromatosis) and the relationship 
between iron deficiency and melisma.
CONCLUSION
Although the serum iron level was lower in nonpregnant 
women with mealsma, it was not significant compared with 
those without melasma. Considering iron deficiency anemia 
as a prevalent problem among young women and as the fact 
that there are not definite treatments for melasma, we may 
suggest adding iron minerals in the treatment of melasma. 
Furthermore, there is a need for further evaluations with 
larger sample sizes regarding this issue.
One limitation of our study was that we did not consider 
family history of melasma in our demographic data 
Table 1: Demographic information compared between 
case and control groups





Age 33.18 (6.1) 32.22 (6.2) >0.05
Marital status (married) 25 (75.7) 28 (77.7) >0.05
Known melasma related 
disease*
0 (0) 0 (0) >0.05
*Specific endocrinologic diseases. The results are presented as mean ± SD or 
n (%) where appropriate. Independent t-test and Chi-square were used for statistical 
analysis. P < 0.05 was considered significant. SD = Standard deviation
Table 2: Comparison of measured variables among case 
and control groups
Variables Group Mean SD P*
TIBC Case 329.48 79.099 0.9
Control 329.38 117.82
Serum iron level Case 85.42 42.17 0.5
Control 102.02 25
Ferritin level Case 46.71 34.81 0.1
Control 38.8 19.68
*t-test. SD = Standard deviation; TIBC = Total iron binding capacity
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among our groups, which are an important predisposing 
factor.
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